Eicosapentaenoic acid in cancer improves body composition and modulates metabolism.

[1]  C. Rock,et al.  Nutrition and physical activity guidelines for cancer survivors , 2012, CA: a cancer journal for clinicians.

[2]  E. Smit,et al.  Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT , 2012, European Journal of Clinical Nutrition.

[3]  R. Murphy,et al.  Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia , 2011, British Journal of Cancer.

[4]  T. Reiman,et al.  Supplementation with fish oil increases first‐line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer , 2011, Cancer.

[5]  M. Ferguson,et al.  Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein‐ and energy‐dense nutritional supplement containing eicosapentaenoic acid , 2011, Head and Neck.

[6]  T. Pepersack.  For an operational definition of cachexia. , 2011, The Lancet. Oncology.

[7]  Paula Ravasco,et al.  Definition and classification of cancer cachexia: an international consensus. , 2011, The Lancet. Oncology.

[8]  T. Reiman,et al.  Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy , 2011, Cancer.

[9]  E. Smit,et al.  Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. , 2010, The Journal of nutrition.

[10]  T. Reiman,et al.  Skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients. , 2010, The Journal of nutrition.

[11]  C. Couet,et al.  Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. , 2010, Progress in lipid research.

[12]  J. Reynolds,et al.  Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) Preserves Lean Body Mass Following Esophageal Cancer Surgery: Results of a Double-Blinded Randomized Controlled Trial , 2009, Annals of surgery.

[13]  P. Beale,et al.  Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial , 2007, Supportive Care in Cancer.

[14]  G. Murray,et al.  Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Bauer,et al.  Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy—a pilot study , 2005, Supportive Care in Cancer.

[16]  P. Novotny,et al.  An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  K. Fearon,et al.  Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids , 2004, British Journal of Cancer.

[18]  N. Aaronson,et al.  Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial , 2003, Gut.

[19]  E. Bruera,et al.  Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  K. Fearon,et al.  Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia , 2001, Lipids.

[21]  D. Mostofsky,et al.  Fatty acids : physiological and behavioral functions , 2001 .

[22]  J. Ross,et al.  Effect of Oral Eicosapentaenoic Acid on Weight Loss in Patients With Pancreatic Cancer , 2000, Nutrition and cancer.

[23]  K. Fearon,et al.  The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer , 1999, British Journal of Cancer.

[24]  K. Fearon,et al.  The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. , 1996, Nutrition.